{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T22:34:19Z","timestamp":1771022059912,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.atherosclerosis.2021.02.004","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T01:01:43Z","timestamp":1612832503000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The incremental value of angiographic features for predicting recurrent cardiovascular events: Insights from the Duke Databank for Cardiovascular Disease"],"prefix":"10.1016","volume":"321","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5745-1636","authenticated-orcid":false,"given":"Michael G.","family":"Nanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric D.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Chiswell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Overton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0990-2548","authenticated-orcid":false,"given":"Adam J.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6197-9860","authenticated-orcid":false,"given":"Ann Marie","family":"Navar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.atherosclerosis.2021.02.004_bib1","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics\u20132019 update: a report from the American heart association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2021.02.004_bib2","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2021.02.004_bib3","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.atherosclerosis.2021.02.004_bib4","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2021.02.004_bib5","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"43","key":"10.1016\/j.atherosclerosis.2021.02.004_bib6","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1093\/eurheartj\/ehx102","article-title":"Identification of vascular patients at very high risk for recurrent cardiovascular events: validation of the current ACC\/AHA very high risk criteria","volume":"38","author":"van den Berg","year":"2017","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2021.02.004_bib7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.115.019861","article-title":"Atherothrombotic risk stratification and the efficacy and safety of vorapaxar in patients with stable ischemic heart disease and previous myocardial infarction","volume":"134","author":"Bohula","year":"2016","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2021.02.004_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008426","article-title":"International validation of the thrombolysis in myocardial infarction (TIMI) risk score for secondary prevention in post-MI patients: a collaborative analysis of the cChronic kidney disease prognosis consortium and the risk validation scientific committee","volume":"7","author":"Mok","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.atherosclerosis.2021.02.004_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.atherosclerosis.2018.03.026","article-title":"External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction","volume":"272","author":"Williams","year":"2018","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2021.02.004_bib10","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1136\/heartjnl-2013-303640","article-title":"Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score","volume":"99","author":"Dorresteijn","year":"2013","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2021.02.004_bib11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.amjmed.2012.01.014","article-title":"An international model to predict recurrent cardiovascular disease","volume":"125","author":"Wilson","year":"2012","journal-title":"Am. J. Med."},{"issue":"16","key":"10.1016\/j.atherosclerosis.2021.02.004_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009217","article-title":"Estimated life expectancy without recurrent cardiovascular events in patients with vascular disease: the SMART-REACH model","volume":"7","author":"Kaasenbrood","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2021.02.004_bib13","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/CIRCULATIONAHA.109.877944","article-title":"Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) substudy","volume":"121","author":"Goto","year":"2010","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2021.02.004_bib14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/CIRCINTERVENTIONS.109.887604","article-title":"Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial","volume":"3","author":"Lansky","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2021.02.004_bib15","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.2337\/dc12-2691","article-title":"Risk of a recurrent cardiovascular event in individuals with type 2 diabetes or intermediate hyperglycemia: the Hoorn Study","volume":"36","author":"van der Heijden","year":"2013","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.02.004_bib16","doi-asserted-by":"crossref","first-page":"9179","DOI":"10.1038\/s41598-017-08741-0","article-title":"Residual risk factors to predict major adverse cardiovascular events in atherosclerotic cardiovascular disease patients with and without diabetes mellitus","volume":"7","author":"Lin","year":"2017","journal-title":"Sci. Rep."},{"issue":"24","key":"10.1016\/j.atherosclerosis.2021.02.004_bib17","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1161\/CIRCULATIONAHA.108.799981","article-title":"Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction","volume":"119","author":"Chan","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.02.004_bib18","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/CIRCOUTCOMES.115.002312","article-title":"Differences in short- and long-term outcomes among older patients with ST-elevation versus non-ST-elevation myocardial infarction with angiographically proven coronary artery disease","volume":"9","author":"Vora","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"24","key":"10.1016\/j.atherosclerosis.2021.02.004_bib19","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1161\/CIRCULATIONAHA.108.799981","article-title":"Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction","volume":"119","author":"Chan","year":"2009","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2021.02.004_bib20","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.jacc.2017.03.556","article-title":"Clinical significance of lipid-rich plaque detected by optical coherence tomography: a 4-year follow-up study","volume":"69","author":"Xing","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.02.004_bib21","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2021.02.004_bib22","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jcmg.2011.05.005","article-title":"Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study","volume":"4","author":"Calvert","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2021.02.004_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001646","article-title":"Traditional risk factors versus biomarkers for prediction of secondary events in patients with stable coronary heart disease: from the Heart and Soul Study","volume":"4","author":"Beatty","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.atherosclerosis.2021.02.004_bib24","doi-asserted-by":"crossref","first-page":"a3083","DOI":"10.1136\/bmj.a3083","article-title":"Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study","volume":"338","author":"de Ruijter","year":"2009","journal-title":"BMJ"},{"issue":"9984","key":"10.1016\/j.atherosclerosis.2021.02.004_bib25","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/S0140-6736(14)61730-X","article-title":"Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials","volume":"385","author":"Mega","year":"2015","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2021.02.004_bib26","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.2010.119","article-title":"Association between a literature-based genetic risk score and cardiovascular events in women","volume":"303","author":"Paynter","year":"2010","journal-title":"J. Am. Med. Assoc."},{"issue":"9750","key":"10.1016\/j.atherosclerosis.2021.02.004_bib27","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(10)61267-6","article-title":"A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses","volume":"376","author":"Ripatti","year":"2010","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2021.02.004_bib28","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2016.5951","article-title":"Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart disease","volume":"315","author":"Ganz","year":"2016","journal-title":"J. Am. Med. Assoc."},{"issue":"2 Pt 1","key":"10.1016\/j.atherosclerosis.2021.02.004_bib29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0002-8703(00)90236-9","article-title":"Primary and subsequent coronary risk appraisal: new results from the Framingham study","volume":"139","author":"D'Agostino","year":"2000","journal-title":"Am. Heart J."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021000617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021000617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:44:53Z","timestamp":1758156293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915021000617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":29,"alternative-id":["S0021915021000617"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.02.004","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The incremental value of angiographic features for predicting recurrent cardiovascular events: Insights from the Duke Databank for Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}